RBA
Richard Bernstein Advisors Portfolio holdings
AUM
$4.05B
This Quarter Return
-11.8%
1 Year Return
+11.12%
3 Year Return
+29.01%
5 Year Return
+50.28%
10 Year Return
+164.51%
AUM
$2.72B
AUM Growth
+$2.72B
(-22%)
Cap. Flow
-$303M
Cap. Flow
% of AUM
-11.14%
Top 10 Holdings %
Top 10 Hldgs %
45.31%
Holding
358
New
12
Increased
28
Reduced
52
Closed
29
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 9.07% |
| 2 | Industrials | 8.02% |
| 3 | Financials | 7.89% |
| 4 | Consumer Discretionary | 5.23% |
| 5 | Healthcare | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Morgan Stanley
MS
$237B
| $3.55M | 0.13% |
89,435
| – | – |
|
152
General Motors
GM
$55B
| $3.54M | 0.13% |
105,933
| – | – |
|
153
Schwab US Large- Cap ETF
SCHX
$58.8B
| $3.51M | 0.13% |
58,849
+4,423
| +8% | +$264K |
|
154
Amphenol
APH
$135B
| $3.5M | 0.13% |
43,133
| – | – |
|
155
Bristol-Myers Squibb
BMY
$96.7B
| $3.48M | 0.13% |
66,900
| – | – |
|
156
CDW
CDW
$21.4B
| $3.44M | 0.13% |
42,428
-22,789
| -35% | -$1.85M |
|
157
Stryker
SYK
$149B
| $3.43M | 0.13% |
21,861
| – | – |
|
158
Vertex Pharmaceuticals
VRTX
$102B
| $3.42M | 0.13% |
20,608
| – | – |
|
159
Schlumberger
SLB
$52.2B
| $3.39M | 0.12% |
93,881
| – | – |
|
160
Cognizant
CTSH
$35.1B
| $3.38M | 0.12% |
53,259
| – | – |
|
161
Capital One
COF
$142B
| $3.37M | 0.12% |
44,639
| – | – |
|
162
Aflac
AFL
$57.1B
| $3.37M | 0.12% |
74,002
| – | – |
|
163
Donaldson
DCI
$9.28B
| $3.36M | 0.12% |
77,391
| – | – |
|
164
Gilead Sciences
GILD
$140B
| $3.35M | 0.12% |
53,594
| – | – |
|
165
Biogen
BIIB
$20.8B
| $3.34M | 0.12% |
11,114
| – | – |
|
166
Intuitive Surgical
ISRG
$158B
| $3.29M | 0.12% |
6,861
| – | – |
|
167
Corning
GLW
$59.4B
| $3.28M | 0.12% |
108,403
-27,354
| -20% | -$826K |
|
168
Becton Dickinson
BDX
$54.3B
| $3.27M | 0.12% |
14,524
| – | – |
|
169
Toro Company
TTC
$7.95B
| $3.25M | 0.12% |
58,219
-21,611
| -27% | -$1.21M |
|
170
Baxter International
BAX
$12.1B
| $3.24M | 0.12% |
49,258
| – | – |
|
171
Eastman Chemical
EMN
$7.76B
| $3.24M | 0.12% |
44,347
| – | – |
|
172
Humana
HUM
$37.5B
| $3.23M | 0.12% |
11,261
| – | – |
|
173
Analog Devices
ADI
$120B
| $3.22M | 0.12% |
37,565
-9,280
| -20% | -$796K |
|
|
DFS
174
DELISTED
Discover Financial Services
DFS
| $3.22M | 0.12% |
54,531
| – | – |
|
175
Illumina
ILMN
$15.2B
| $3.21M | 0.12% |
10,701
| – | – |
|